JP2023549469A5 - - Google Patents
Info
- Publication number
- JP2023549469A5 JP2023549469A5 JP2023524397A JP2023524397A JP2023549469A5 JP 2023549469 A5 JP2023549469 A5 JP 2023549469A5 JP 2023524397 A JP2023524397 A JP 2023524397A JP 2023524397 A JP2023524397 A JP 2023524397A JP 2023549469 A5 JP2023549469 A5 JP 2023549469A5
- Authority
- JP
- Japan
- Prior art keywords
- residue
- lys
- ipr
- arg
- forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063094839P | 2020-10-21 | 2020-10-21 | |
| US63/094,839 | 2020-10-21 | ||
| PCT/CA2021/051486 WO2022082312A1 (en) | 2020-10-21 | 2021-10-21 | Novel cxcr4-targeting compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549469A JP2023549469A (ja) | 2023-11-27 |
| JP2023549469A5 true JP2023549469A5 (https=) | 2024-10-28 |
Family
ID=81291055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524397A Pending JP2023549469A (ja) | 2020-10-21 | 2021-10-21 | 新規ｃｘｃｒ４標的化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240100203A1 (https=) |
| EP (1) | EP4232459A4 (https=) |
| JP (1) | JP2023549469A (https=) |
| KR (1) | KR20230092906A (https=) |
| CN (1) | CN116457028A (https=) |
| AU (1) | AU2021366975A1 (https=) |
| CA (1) | CA3194483A1 (https=) |
| IL (1) | IL301342A (https=) |
| WO (1) | WO2022082312A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4511384A1 (en) * | 2022-04-20 | 2025-02-26 | Provincial Health Services Authority | Cxcr4-targeting compounds, and methods of making and using the same |
| US12614326B2 (en) * | 2023-05-03 | 2026-04-28 | GE Precision Healthcare LLC | Methods and systems for scatter and tailing correction |
| US12514939B2 (en) | 2024-02-14 | 2026-01-06 | Alpha-9 Oncology, Inc. | Stable radiopharmaceutical compositions and uses thereof |
| WO2025171492A1 (en) * | 2024-02-14 | 2025-08-21 | Alpha-9 Oncology Inc. | Stable radiopharmaceutical compositions and uses thereof |
| WO2025218761A1 (zh) * | 2024-04-17 | 2025-10-23 | 晶核生物医药科技(上海)有限公司 | 环状肽类化合物、其药物组合物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006035705A1 (de) * | 2006-08-01 | 2008-02-07 | Robert Bosch Gmbh | Kolben einer Fahrzeugbremsanlagen-Kolbenpumpe |
| EP2377579A1 (en) * | 2007-05-30 | 2011-10-19 | Eli Lilly and Company | Cyclic peptide CXCR4 antagonists |
| CN113150068B (zh) * | 2017-09-20 | 2023-04-04 | 尚华医药科技(江西)有限公司 | 一种肽类化合物、其应用及含其的组合物 |
| JP2021165234A (ja) * | 2018-07-03 | 2021-10-14 | 富士フイルム富山化学株式会社 | Ｃｘｃｒ４結合性化合物もしくはその塩またはそれらと金属との錯体 |
| US20220218852A1 (en) * | 2019-04-18 | 2022-07-14 | Provincial Health Services Authority | Novel radiolabelled cxcr4-targeting compounds for diagnosis and therapy |
-
2021
- 2021-10-21 JP JP2023524397A patent/JP2023549469A/ja active Pending
- 2021-10-21 AU AU2021366975A patent/AU2021366975A1/en active Pending
- 2021-10-21 IL IL301342A patent/IL301342A/en unknown
- 2021-10-21 CN CN202180071425.XA patent/CN116457028A/zh active Pending
- 2021-10-21 WO PCT/CA2021/051486 patent/WO2022082312A1/en not_active Ceased
- 2021-10-21 CA CA3194483A patent/CA3194483A1/en active Pending
- 2021-10-21 EP EP21881418.4A patent/EP4232459A4/en active Pending
- 2021-10-21 KR KR1020237013276A patent/KR20230092906A/ko active Pending
- 2021-10-21 US US18/032,680 patent/US20240100203A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023549469A5 (https=) | ||
| JP5676673B2 (ja) | 癌の画像化および処置 | |
| JP2021505532A (ja) | 画像化および内部放射線療法のためのｐｓｍａリガンド | |
| KR20200056979A (ko) | 방사성 약제 | |
| CN116457028A (zh) | 新型的靶向cxcr4的化合物 | |
| US20250288704A1 (en) | Cxcr4-ligands for diagnostic and therapeutic use and precursors thereof | |
| WO2020053255A1 (en) | Therapeutic and diagnostic agents for cancer | |
| JP2025513489A5 (https=) | ||
| AU2019338221B2 (en) | CXCR4-targeted diagnostic and therapeutic agents with reduced species selectivity | |
| AU2023257191A1 (en) | Cxcr4-targeting compounds, and methods of making and using the same | |
| EP3149024B1 (en) | Cytotoxic dolaproine-dolaisoleuine peptide derivatives for the treatment of cancer | |
| JP6280507B2 (ja) | キレート剤 | |
| JP4318985B2 (ja) | ソマトスタチンアナログ誘導体およびその利用 | |
| KR20220118464A (ko) | 암의 영상화 및 치료법을 위한 개선된 약동학을 갖는 화합물 | |
| EA044558B1 (ru) | Агенты для терапии и диагностики рака | |
| HK40029075A (en) | Radioactive drug |